Literature DB >> 2281823

Heterogeneity of human bone.

J T Ninomiya1, R P Tracy, J D Calore, M A Gendreau, R J Kelm, K G Mann.   

Abstract

Matched samples of bone from the lumbar spine and tibia were obtained at autopsy from three adult males who had no known evidence of metabolic bone disease at the time of their demise. The soluble noncollagenous bone proteins were quantitatively extracted from these samples and assayed for the relative content of two bone-associated proteins, osteocalcin and osteonectin. When compared to trabecular bone, cortical bone had higher levels of osteocalcin and much lower levels of osteonectin. When concentration is expressed per gram of dried bone, the osteocalcin excess in cortical bone ranged from 30- to 32-fold, and the osteonectin excess in trabecular bone ranged from 21- to 47-fold. These differences were significant (P less than 0.01) using analysis of variance. We conclude that the human skeleton is not homogeneous with regard to these biochemical markers and that cortical and trabecular bone are biochemically quite distinct. This implies that these two types of bone may be subject to distinct regulatory mechanisms and that global assessments of skeletal function and bone quality based upon soluble markers should be applied with caution. The data also imply that a differential assessment of skeletal performance may be possible using biochemical serum markers.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2281823     DOI: 10.1002/jbmr.5650050906

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  17 in total

1.  Separation of newly formed bone from older compact bone reveals clear compositional differences in bone matrix.

Authors:  Ronald J Midura; Sharon B Midura; Xiaowei Su; Jeffrey P Gorski
Journal:  Bone       Date:  2011-09-18       Impact factor: 4.398

2.  A short isoform of Col9a1 supports alveolar bone repair.

Authors:  K Ting; H Ramachandran; K S Chung; N Shah-Hosseini; B R Olsen; I Nishimura
Journal:  Am J Pathol       Date:  1999-12       Impact factor: 4.307

3.  FTIR microspectroscopic analysis of human osteonal bone.

Authors:  E P Paschalis; E DiCarlo; F Betts; P Sherman; R Mendelsohn; A L Boskey
Journal:  Calcif Tissue Int       Date:  1996-12       Impact factor: 4.333

Review 4.  Effects of bone matrix proteins on fracture and fragility in osteoporosis.

Authors:  Grażyna E Sroga; Deepak Vashishth
Journal:  Curr Osteoporos Rep       Date:  2012-06       Impact factor: 5.096

5.  Osteopenia and decreased bone formation in osteonectin-deficient mice.

Authors:  A M Delany; M Amling; M Priemel; C Howe; R Baron; E Canalis
Journal:  J Clin Invest       Date:  2000-04       Impact factor: 14.808

Review 6.  The Utility of Biomarkers in Osteoporosis Management.

Authors:  Patrick Garnero
Journal:  Mol Diagn Ther       Date:  2017-08       Impact factor: 4.074

7.  Bone tissue composition varies across anatomic sites in the proximal femur and the iliac crest.

Authors:  Eve Donnelly; Dennis S Meredith; Joseph T Nguyen; Adele L Boskey
Journal:  J Orthop Res       Date:  2011-10-27       Impact factor: 3.494

8.  Cortical versus trabecular bone mass: influence of activity on both bone components.

Authors:  H Rico; J González-Riola; M Revilla; L F Villa; F Gómez-Castresana; J Escribano
Journal:  Calcif Tissue Int       Date:  1994-06       Impact factor: 4.333

9.  Total and regional bone mineral content and fracture rate in postmenopausal osteoporosis treated with salmon calcitonin: a prospective study.

Authors:  H Rico; M Revilla; E R Hernández; L F Villa; M Alvarez de Buergo
Journal:  Calcif Tissue Int       Date:  1995-03       Impact factor: 4.333

10.  Responsiveness of gene expression markers of osteoblastic and osteoclastic activity to calcitonin in the appendicular and axial skeleton of the rat in vivo.

Authors:  L G Jenis; B Ongphiphadhanakul; L E Braverman; G S Stein; J B Lian; R Lew; D T Baran
Journal:  Calcif Tissue Int       Date:  1994-06       Impact factor: 4.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.